Skip to main content
Erschienen in: Acta Diabetologica 4/2015

01.08.2015 | Original Article

The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction

verfasst von: Mohsen Janghorbani, Siedeh Zinab Almasi, Masoud Amini

Erschienen in: Acta Diabetologica | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Aims

Previous study has reported that triglycerides-glucose (TyG) index, a product of triglycerides and fasting plasma glucose (FPG), might be useful in the prediction of incident type 2 diabetes (T2D). We evaluated the ability of the TyG index compared to FPG and OGTT as possible diabetes predictor in nondiabetic first-degree relatives (FDRs) of patients with T2D.

Methods

A total of 1,488 FDRs without diabetes of consecutive patients with T2D 30–70 years old (361 men and 1,127 women) were examined and followed for a mean (SD) of 6.9 (1.7) years for diabetes incidence. We examined the incidence of diabetes across quartiles of the TyG index and plotted a receiver operating characteristic (ROC) curve to assess discrimination. At baseline and through follow-up, participants underwent a standard 75-g two-hour oral glucose tolerance test.

Results

During 10,124 person-years of follow-up, 41 men and 154 women developed T2D. Those in the top quartile of TyG index were 3.4 times more likely to develop T2D than those in the bottom quartile (odds ratio 3.36; 95 % CI 1.83, 6.19). On ROC curve analysis, a higher area under the ROC was found for FPG (76.2; 95 % CI 71.9, 80.6), 1-hPG (81.0, 95 % CI 77.2, 84.9) and 2-hPG (76.5; 95 % CI 72.3, 80.8) than for TyG index (65.1; 95 % CI 60.5, 69.7).

Conclusions

TyG index is predicted T2D in high-risk individuals in Iran but FPG, 1-hPG and 2-hPG appeared to be more robust predictor of T2D in our study population.
Literatur
1.
Zurück zum Zitat Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321PubMedCrossRef Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321PubMedCrossRef
2.
Zurück zum Zitat Guariguata L (2012) By the numbers: new estimates from the IDF diabetes atlas update for 2012. Diabetes Res Clin Pract 98:524–525PubMedCrossRef Guariguata L (2012) By the numbers: new estimates from the IDF diabetes atlas update for 2012. Diabetes Res Clin Pract 98:524–525PubMedCrossRef
3.
Zurück zum Zitat Shera S, Jawad F, Maqsood A (2007) Prevalence of diabetes in Pakistan. Diabetes Res Clin Pract 76:219–222PubMedCrossRef Shera S, Jawad F, Maqsood A (2007) Prevalence of diabetes in Pakistan. Diabetes Res Clin Pract 76:219–222PubMedCrossRef
4.
Zurück zum Zitat Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S et al (2002) Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 25:1551–1556PubMedCrossRef Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S et al (2002) Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 25:1551–1556PubMedCrossRef
5.
Zurück zum Zitat Ashraf H, Rashidi A, Noshad S, Khalilzadeh O, Esteghamati A (2011) Epidemiology and risk factors of the cardiometabolic syndrome in the Middle East. Expert Rev Cardiovasc Ther 9:309–320PubMedCrossRef Ashraf H, Rashidi A, Noshad S, Khalilzadeh O, Esteghamati A (2011) Epidemiology and risk factors of the cardiometabolic syndrome in the Middle East. Expert Rev Cardiovasc Ther 9:309–320PubMedCrossRef
6.
Zurück zum Zitat Chodick G, Heymann AD, Shalev V, Kookia E (2003) The epidemiology of diabetes in a large Israeli HMO. Eur J Epidemiol 18:1143–1146PubMedCrossRef Chodick G, Heymann AD, Shalev V, Kookia E (2003) The epidemiology of diabetes in a large Israeli HMO. Eur J Epidemiol 18:1143–1146PubMedCrossRef
7.
Zurück zum Zitat Al-Mahroos F, McKeigue PM (1998) High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol. Diabetes Care 21:936–942PubMedCrossRef Al-Mahroos F, McKeigue PM (1998) High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol. Diabetes Care 21:936–942PubMedCrossRef
8.
Zurück zum Zitat Motlagh B, O’Donnell M, Yusuf S (2009) Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Eur J Cardiovasc Prev Rehabil 16:268–280PubMedCrossRef Motlagh B, O’Donnell M, Yusuf S (2009) Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Eur J Cardiovasc Prev Rehabil 16:268–280PubMedCrossRef
9.
Zurück zum Zitat Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRef Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRef
10.
Zurück zum Zitat Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al (2002) Diabetes prevention program research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al (2002) Diabetes prevention program research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef
11.
Zurück zum Zitat Abbasi A, Peelen LM, Corpeleijn E, van der Schouw YT, Stolk RP, Spijkerman AM et al (2012) Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ 345:e5900PubMedCentralPubMedCrossRef Abbasi A, Peelen LM, Corpeleijn E, van der Schouw YT, Stolk RP, Spijkerman AM et al (2012) Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ 345:e5900PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Buijsse B, Simmons RK, Griffin SJ, Schulze MB (2011) Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 33:46–62PubMedCentralPubMedCrossRef Buijsse B, Simmons RK, Griffin SJ, Schulze MB (2011) Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 33:46–62PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Noble D, Mathur R, Dent T, Meads C, Greenhalgh T (2011) Risk models and scores for type 2 diabetes: systematic review. BMJ 343:d7163 Noble D, Mathur R, Dent T, Meads C, Greenhalgh T (2011) Risk models and scores for type 2 diabetes: systematic review. BMJ 343:d7163
14.
Zurück zum Zitat Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T et al (2005) Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353:1454–1462PubMedCrossRef Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T et al (2005) Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353:1454–1462PubMedCrossRef
16.
Zurück zum Zitat Janghorbani M, Amini M (2011) Normal fasting plasma glucose and risk of prediabetes and type 2 diabetes: the Isfahan Diabetes Prevention Study. Rev Diabet Stud 8:490PubMedCentralPubMedCrossRef Janghorbani M, Amini M (2011) Normal fasting plasma glucose and risk of prediabetes and type 2 diabetes: the Isfahan Diabetes Prevention Study. Rev Diabet Stud 8:490PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6:299–304PubMedCrossRef Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6:299–304PubMedCrossRef
18.
Zurück zum Zitat Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernandez Gonzalez SO et al (2010) The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 95:3347–3351PubMedCrossRef Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernandez Gonzalez SO et al (2010) The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 95:3347–3351PubMedCrossRef
19.
Zurück zum Zitat Abbasi F, Reaven GM (2011) Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterol. Metabolism 60:1673–1676PubMedCrossRef Abbasi F, Reaven GM (2011) Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterol. Metabolism 60:1673–1676PubMedCrossRef
20.
Zurück zum Zitat Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909–915PubMedCrossRef Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909–915PubMedCrossRef
21.
Zurück zum Zitat DeFronzo RA (2009) From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58:773–795PubMedCentralPubMedCrossRef DeFronzo RA (2009) From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58:773–795PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Lee SH, Kwon HS, Park YM, Ha HS, Jeong SH, Yang HK et al (2014) Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC) study. PLoS One 9(2):e90430PubMedCentralPubMedCrossRef Lee SH, Kwon HS, Park YM, Ha HS, Jeong SH, Yang HK et al (2014) Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC) study. PLoS One 9(2):e90430PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Amini M, Janghorbani M (2007) Diabetes and impaired glucose regulation in first degree relatives of patients with type 2 diabetes in Isfahan, Iran: prevalence and risk factors. Rev Diabet Stud 4(169):76 Amini M, Janghorbani M (2007) Diabetes and impaired glucose regulation in first degree relatives of patients with type 2 diabetes in Isfahan, Iran: prevalence and risk factors. Rev Diabet Stud 4(169):76
24.
Zurück zum Zitat American Diabetes Association (2008) Executive summary: Standard of Medical Care in Diabetes-2008. Diabetes Care 31:S5–S11 American Diabetes Association (2008) Executive summary: Standard of Medical Care in Diabetes-2008. Diabetes Care 31:S5–S11
25.
Zurück zum Zitat World Medical Association (2009) Declaration of Helsinki, Ethical principles for medical research involving human subjects. J Indian Med Assoc 107:403–405 World Medical Association (2009) Declaration of Helsinki, Ethical principles for medical research involving human subjects. J Indian Med Assoc 107:403–405
26.
Zurück zum Zitat American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–S69PubMedCentralCrossRef American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–S69PubMedCentralCrossRef
27.
Zurück zum Zitat Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed
28.
Zurück zum Zitat Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care suppl 1:S5–S20 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care suppl 1:S5–S20
29.
Zurück zum Zitat Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef
30.
Zurück zum Zitat DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845PubMedCrossRef DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845PubMedCrossRef
31.
Zurück zum Zitat Alyass A, Almgren P, Akerlund M, Dushoff J, Isomaa B, Nilsson P et al (2015) Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts. Diabetologia 58:87–97PubMedCrossRef Alyass A, Almgren P, Akerlund M, Dushoff J, Isomaa B, Nilsson P et al (2015) Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts. Diabetologia 58:87–97PubMedCrossRef
32.
Zurück zum Zitat Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D et al (2007) Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78:305–312PubMedCrossRef Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D et al (2007) Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78:305–312PubMedCrossRef
33.
Zurück zum Zitat Janghorbani M, Amini M (2009) Comparison of fasting glucose with post-load glucose values and glycated hemoglobin for prediction of type 2 diabetes: the Isfahan diabetes prevention study. Rev Diabet Stud 6:117–123PubMedCentralPubMedCrossRef Janghorbani M, Amini M (2009) Comparison of fasting glucose with post-load glucose values and glycated hemoglobin for prediction of type 2 diabetes: the Isfahan diabetes prevention study. Rev Diabet Stud 6:117–123PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Janghorbani M, Amini M (2012) Incidence of type 2 diabetes by HbA1c and OGTT: the Isfahan Diabetes Prevention Study. Acta Diabetol 49(Suppl 1):S73–S79PubMedCrossRef Janghorbani M, Amini M (2012) Incidence of type 2 diabetes by HbA1c and OGTT: the Isfahan Diabetes Prevention Study. Acta Diabetol 49(Suppl 1):S73–S79PubMedCrossRef
35.
Zurück zum Zitat Bastard JP, Lavoie ME, Messier V, Prud’homme D, Rabasa-Lhoret R (2012) Evaluation of two new surrogate indices including parameters not using insulin to assess insulin sensitivity/resistance in non-diabetic postmenopausal women: a MONET group study. Diabetes Metab 38:258–263PubMedCrossRef Bastard JP, Lavoie ME, Messier V, Prud’homme D, Rabasa-Lhoret R (2012) Evaluation of two new surrogate indices including parameters not using insulin to assess insulin sensitivity/resistance in non-diabetic postmenopausal women: a MONET group study. Diabetes Metab 38:258–263PubMedCrossRef
36.
Zurück zum Zitat Vasques AC, Novaes FS, de Oliveira MDS, Souza JR, Yamanaka A, Pareja JC et al (2011) TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 93:e98–e100PubMedCrossRef Vasques AC, Novaes FS, de Oliveira MDS, Souza JR, Yamanaka A, Pareja JC et al (2011) TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 93:e98–e100PubMedCrossRef
Metadaten
Titel
The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction
verfasst von
Mohsen Janghorbani
Siedeh Zinab Almasi
Masoud Amini
Publikationsdatum
01.08.2015
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 4/2015
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-014-0709-5

Weitere Artikel der Ausgabe 4/2015

Acta Diabetologica 4/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.